Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity. - Wikidata - awgldk - TriplyDB

Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity.

Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity.

http://www.wikidata.org/entity/Q30300159

about

Oncolytic Viruses: Therapeutics With an Identity Crisis Viro-immune therapy: A new strategy for treatment of pancreatic cancer Adenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of Cancer Viruses as nanomedicine for cancer Trial Watch-Oncolytic viruses and cancer therapy Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer Therapies.Oncolytic Virus-Mediated Targeting of PGE2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to Immunotherapy.Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model.OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution.Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.All that glitters is not gold: the need to consider desirable and undesirable immune aspects of oncolytic virus therapy.Oncolytic immunotherapy: The new clinical outbreak.Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential.Molecular Effects of Stromal-Selective Targeting by uPAR-Retargeted Oncolytic Virus in Breast Cancer.Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy.Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma.Oncolytic viruses-immunotherapeutics on the rise.Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes.The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.Effects of increased Kindlin-2 expression in bladder cancer stromal fibroblasts A cross-talk network that facilitates tumor virotherapy.Human CAFs promote lymphangiogenesis in ovarian cancer via the Hh-VEGF-C signaling axis TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma.Personalized virotherapy in cancer.Prospects for combined use of oncolytic viruses and CAR T-cells.Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.Oncolytic Virotherapy and the Tumor Microenvironment.Lysyl oxidase activates cancer stromal cells and promotes gastric cancer progression: quantum dot-based identification of biomarkers in cancer stromal cells.Capitalizing on Cancer Specific Replication: Oncolytic Viruses as a Versatile Platform for the Enhancement of Cancer Immunotherapy Strategies.Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy.Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference.

P2860

Q26741020-893D9723-BD0C-419C-A280-B7F1CD94D59B Q26774641-EB8B1BD8-2EE2-453B-8B67-B0DD5B819900 Q27317286-47B028ED-2399-414B-8734-43467E57E938 Q27690636-2D57E968-011F-4267-8B54-8A0351F7E497 Q28072347-A32C6965-C590-4E22-A51A-C01735104F7D Q33679505-F1C3B1B4-FB90-47C1-AE00-CDD62BA2418A Q36751597-A7E146BA-3AFB-4BF2-94FF-6E283ACD6CBE Q36796025-4E5852B1-5601-4A3D-A930-B22388769189 Q37129177-381494E0-7746-447B-9CB6-A6C2F721BC6C Q37709496-597F3702-9AD5-43F8-9A09-04890C13CF30 Q37718560-318D61C4-CC18-405B-B793-0EC21E57E49D Q38400073-CFE893C3-20C1-4934-BEC2-B6D1C48C0AC0 Q38563884-7F2FCA51-D418-47F6-94F9-7EE5AD1CA146 Q38564425-4D2FE961-130A-4B44-A1D1-59FC3A60E149 Q38601861-88FFA16F-6459-4765-86D4-49A6278054F6 Q38692304-6F7C51E4-4AF8-415A-A2DF-AE8655833185 Q38746023-4F18BBAB-89C9-4350-A57E-BFD8F688302E Q38781322-96CA86C7-56D2-44AC-92D6-E2AC189A4C64 Q38919107-A956DA5C-48CA-465F-8755-9A4561C9C1CC Q39359422-1ECA21EF-75D9-4692-8DD2-483889C8367C Q40444191-C86BA59A-868E-46BA-9EF5-86A2124933B5 Q41612367-890A0FE2-C7AA-43C2-B87F-81BF90813FB6 Q41755608-E3C751AF-A12D-4D0C-A2C2-0D86CBF44F3A Q42366544-6BF05668-EFA1-43FD-975B-E2C0DCCFE8F1 Q42373489-1DF2DA80-24CE-47CE-91A1-482055D6EF99 Q42430932-7C53F482-2924-47AC-985A-81D11F2A76EA Q47103891-15388991-7F67-405F-A97A-8E2DF8E66D67 Q47365404-716B58FB-A096-4423-B104-9B9E2A340A66 Q47560690-C2DFC3E1-22D2-4574-84BB-231E59B07C4D Q49177437-9DECBF4A-459D-485A-845E-D70119BF6A94 Q50865520-C3417BD0-9CBD-4506-A667-F0BF9977A953 Q54221621-D7BFEFC5-B4CD-4A46-B9C3-084819389631 Q55309857-10FFB7C3-F128-47B4-A690-9A06D71A71B9

P2860

Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity.

http://www.wikidata.org/entity/Q30300159

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Reciprocal cellular cross-talk ...... otes oncolytic virus activity.

@ast

Reciprocal cellular cross-talk ...... otes oncolytic virus activity.

@en

type

label

Reciprocal cellular cross-talk ...... otes oncolytic virus activity.

@ast

Reciprocal cellular cross-talk ...... otes oncolytic virus activity.

@en

prefLabel

Reciprocal cellular cross-talk ...... otes oncolytic virus activity.

@ast

Reciprocal cellular cross-talk ...... otes oncolytic virus activity.

@en

P1433

Q30300159-51DE6D0D-3FE3-4984-9DD2-26B780687395

P1476

Q30300159-5B05496F-AE70-4331-8522-B01D9B6D384B

P2093

Q30300159-0043E313-C13B-4B54-8631-D8A21A7A6A07

Q30300159-03C85B6E-CA31-42CF-95AE-410AD973F867

Q30300159-14FD2A45-5B20-4A34-9B9A-30F924447489

Q30300159-1A845A3A-DD79-44B4-AEAC-28A27903816C

Q30300159-23042506-84AA-4582-B573-F492DB73F323

Q30300159-23B7259E-3BA5-4EB4-A0F3-E10A341826B6

Q30300159-257F9A67-E7B7-415F-9CEE-F62CA878AF6E

Q30300159-5643499F-ADB3-4C19-B3A6-E0E0E264A2FE

Q30300159-5C138C19-9929-413D-8040-0F4B0DC6B389

Q30300159-5D04994A-D61E-469D-99D7-0EEB243B4157

P2860

Q30300159-01F97F62-B639-4F29-9A9C-CBE94778A47D

Q30300159-073F44CF-958F-4F60-A32C-A4B106067D87

Q30300159-07F66608-D5B0-488C-B9D3-3F56F3543248

Q30300159-08577013-4797-45ED-88AA-195DC4583C85

Q30300159-08E5D69D-C64E-47C4-8E72-200548E96ABA

Q30300159-0AA15C12-DADE-4499-965A-A4CA1E5DDCE1

Q30300159-0AB7FCCD-298C-458D-92B7-3ABA561DEEA4

Q30300159-0BC38B10-BFED-41BA-99AE-28AE7817C738

Q30300159-1067B65A-9ECA-4029-86DE-566479D306DA

Q30300159-223AEAC3-FEDD-4C13-BBF4-7B1B6B4EED67

P2888

Q30300159-56BED1FB-3102-4BC3-9311-28EEE581E8ED

P304

Q30300159-5021F987-574E-46B0-B451-19A73886F7A8

P31

Q30300159-D135C7F6-C35E-4132-BB51-3CB7D5B53980

P356

Q30300159-49E0E13C-1241-43A6-B46A-413E116EC071

P407

Q30300159-A0A3AF98-2AAA-4D92-9ECC-1B68637BE7FF

P433

Q30300159-F02C6990-3749-424D-830F-6ECF643614E8

P478

Q30300159-2E9C1B9B-76DD-47A6-AB28-D15E354EDC65

P50

Q30300159-435B054F-1D46-4ACF-82DA-594E6C19F14B

Q30300159-7A740405-259F-4087-9CBA-45A907C6679B

Q30300159-9362BD2D-C4CB-4EED-A186-5E0E5FA5A88B

Q30300159-D5B87B3D-8263-46AC-A323-8217C0B7ABA1

Q30300159-F67F9A67-383A-4A95-BBF9-1D7D20CD1B76

P577

Q30300159-71F83C22-C8B1-48BB-BAE0-3532934598EE

P698

Q30300159-F745C8D3-9209-4C96-9F96-3F5742CE9E69

P921

Q30300159-A9903582-8DAF-4695-BD2F-AA54FFA22828

P356

P1433

Nature Medicine

P1476

Reciprocal cellular cross-talk ...... motes oncolytic virus activity

@en

P2093

Almohanad Alkayyal

http://www.w3.org/2001/XMLSchema#string

Avijit Chatterjee

http://www.w3.org/2001/XMLSchema#string

Brian D Lichty

http://www.w3.org/2001/XMLSchema#string

Christiano Tanese de Souza

http://www.w3.org/2001/XMLSchema#string

Christina L Addison

http://www.w3.org/2001/XMLSchema#string

Cory Batenchuk

http://www.w3.org/2001/XMLSchema#string

Daniela Ben Neriah

http://www.w3.org/2001/XMLSchema#string

David Bellamy

http://www.w3.org/2001/XMLSchema#string

David F Stojdl

http://www.w3.org/2001/XMLSchema#string

Donald Bastin

http://www.w3.org/2001/XMLSchema#string

P2860

RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate

RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway

INTERFEROME: the database of interferon regulated genes

Cancer immunoediting from immune surveillance to immune escape

Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

A new mathematical model for relative quantification in real-time RT-PCR

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

Fibroblasts in cancer

GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists

P2888

P304

530-536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.3848

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Carolina S Ilkow

P577

2015-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25894825

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus